The State of Gujarat vs. Cadila Healthcare Ltd.
Background
Cadila Healthcare manufactured a product called "KADIPROL," used in poultry rearing, containing an anti-coccidial ingredient and Vitamin K3. The Deputy Commissioner of Sales Tax classified it as a "Drug and Medicine" (taxable) under the Gujarat Sales Tax Act, and the Sales Tax Tribunal agreed. However, the Gujarat High Court, on a reference, held the product should instead be classified as tax-exempt "Poultry Feed." The State of Gujarat appealed to the Supreme Court, arguing the High Court had not properly engaged with the Tribunal's detailed reasoning about the product's medicinal composition and purpose.
Decision Breakdown
The Supreme Court agreed there was merit in the State's complaint that the High Court's judgment merely cited two precedents without a detailed, fact-specific examination of whether KADIPROL was genuinely a nutritional poultry feed additive or a medicine. Ordinarily, the Court said, it would have sent the matter back to the High Court for a fresh, reasoned decision. However, since it was undisputed that there was no longer any pending tax demand against Cadila for this issue (all assessments were closed) and the classification question had become purely academic with zero revenue effect, the Court declined to go through that exercise. Instead, it simply closed the proceedings, leaving the broader legal question about the "common parlance test" for classifying such borderline products open to be decided in a future case with a live dispute.
Lesson Learnt
Courts will generally avoid deciding a legal question purely for its academic or precedent value once the underlying dispute has become moot (here, with no actual tax liability remaining), even if one side's argument on the merits appeared to have some strength, and litigants should be aware that appeals can be closed without a substantive ruling if there's nothing practical left to decide.